321 related articles for article (PubMed ID: 17166850)
1. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
2. LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.
Yanagida K; Ishii S; Hamano F; Noguchi K; Shimizu T
J Biol Chem; 2007 Feb; 282(8):5814-24. PubMed ID: 17172642
[TBL] [Abstract][Full Text] [Related]
3. P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
Lee M; Choi S; Halldén G; Yo SJ; Schichnes D; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G641-54. PubMed ID: 19679818
[TBL] [Abstract][Full Text] [Related]
4. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.
Lee CW; Rivera R; Gardell S; Dubin AE; Chun J
J Biol Chem; 2006 Aug; 281(33):23589-97. PubMed ID: 16774927
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho.
Hilal-Dandan R; Means CK; Gustafsson AB; Morissette MR; Adams JW; Brunton LL; Heller Brown J
J Mol Cell Cardiol; 2004 Apr; 36(4):481-93. PubMed ID: 15081308
[TBL] [Abstract][Full Text] [Related]
6. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation.
Mikelis CM; Palmby TR; Simaan M; Li W; Szabo R; Lyons R; Martin D; Yagi H; Fukuhara S; Chikumi H; Galisteo R; Mukouyama YS; Bugge TH; Gutkind JS
J Biol Chem; 2013 Apr; 288(17):12232-43. PubMed ID: 23467409
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induces neurite branch formation through LPA3.
Furuta D; Yamane M; Tsujiuchi T; Moriyama R; Fukushima N
Mol Cell Neurosci; 2012 May; 50(1):21-34. PubMed ID: 22465231
[TBL] [Abstract][Full Text] [Related]
9. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.
Takashima S; Sugimoto N; Takuwa N; Okamoto Y; Yoshioka K; Takamura M; Takata S; Kaneko S; Takuwa Y
Cardiovasc Res; 2008 Sep; 79(4):689-97. PubMed ID: 18480127
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
11. Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11.
Vogt S; Grosse R; Schultz G; Offermanns S
J Biol Chem; 2003 Aug; 278(31):28743-9. PubMed ID: 12771155
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
Yanagida K; Masago K; Nakanishi H; Kihara Y; Hamano F; Tajima Y; Taguchi R; Shimizu T; Ishii S
J Biol Chem; 2009 Jun; 284(26):17731-41. PubMed ID: 19386608
[TBL] [Abstract][Full Text] [Related]
13. The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12.
Liao Z; Seye CI; Weisman GA; Erb L
J Cell Sci; 2007 May; 120(Pt 9):1654-62. PubMed ID: 17452627
[TBL] [Abstract][Full Text] [Related]
14. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
15. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2.
Seasholtz TM; Radeff-Huang J; Sagi SA; Matteo R; Weems JM; Cohen AS; Feramisco JR; Brown JH
J Neurochem; 2004 Oct; 91(2):501-12. PubMed ID: 15447683
[TBL] [Abstract][Full Text] [Related]
16. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
[TBL] [Abstract][Full Text] [Related]
17. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.
Hains MD; Wing MR; Maddileti S; Siderovski DP; Harden TK
Mol Pharmacol; 2006 Jun; 69(6):2068-75. PubMed ID: 16554409
[TBL] [Abstract][Full Text] [Related]
18. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
[TBL] [Abstract][Full Text] [Related]
19. Strategy for the identification of GPR23/LPA4 receptor agonists and inverse agonists.
Wong SH; Mallari R; Graham M; Atangan L; Lu SC; Zhao X; Gu W; Lee PH
Assay Drug Dev Technol; 2010 Aug; 8(4):459-70. PubMed ID: 20482379
[TBL] [Abstract][Full Text] [Related]
20. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Noguchi K; Ishii S; Shimizu T
J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
